# Oruka Therapeutics, Inc.: Form 8-K, filed Oct 4, 2024

- Company: [Oruka Therapeutics, Inc.](/companies/orka.md) (CIK 907654)
- Form: 8-K
- Filed: 2024-10-04
- Accepted by EDGAR: Oct 4, 2024, 16:05 ET
- Period: 2024-10-03
- Accession: 0001213900-24-085543
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/907654/000121390024085543/ea0216746-8k_oruka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/907654/000121390024085543/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/907654/000121390024085543/ea0216746-8k_oruka.htm

Filed Oct 4, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-085543. Last ingested by Listed: Nov 2, 2026, 20:24 ET. No prices; not investment advice.